The Impact of Cardiovascular Complications on Mortality and Public Health in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study

Hasnat Karim¹*, Azizur Rahman², Md. Fatin¹

Understanding these relationships will help inform the public health and clinical initiatives intended to positively change the outcome and quality of life.

Abstract

Background: Hepatocellular carcinoma (HCC) is unmoving one of the deadliest cancers. It's single among malignancies outstanding to its cumulative occurrence. The value of overall survival is impacted by multiple factors such as stage and presence of metastatic disease, but there is a considerable focus on treatment-related survival outcomes. Cardiovascular morbidity in advanced HCC patients is, however, one of the least researched problems regarding healthcare resource utilization and cost. Methods: We showed a reflective unit study, which analyzed the data of 235 HCC affected role crossways three tertiary care hospitals. The related details were collected through electrical health records and comprised age, gender, clinical past, oncologic history, and comorbid cardiovascular diseases. Important cardiovascular actions of interest included congestive heart failure, arrhythmias, myocardial infarction, stroke, and existence. To perform results analysis, we advanced multivariable COX proportional dangers replicas for each result to estimate the danger of opposing cardiovascular proceedings. Results: Ensuing a HCC diagnosis, 28.5% of patients had oncological cardiovascular complications, the most public being: heart failure (34.3%), arrhythmias (31.3%), myocardial infarction (22.4%), and stroke (11.9%). Identified independent risk issues were: hypertension (HR 2.12; p<0.001), diabetes (HR 1.76; p=0.006), and extra advanced growth phase locally (HR 2.49; p<0.001). Those with cardiovascular proceedings experienced considerably lower survival compared to patients without (9.5 months versus 17.8 months <0.001). Conclusion: cardiovascular problems are prevalent and deteriorate survival prognosis in HCC patients. There is need for optimal cardio-oncology intercessions to improve outcome and healthcare spending efficiency in this high-risk population.

Keywords: Hepatocellular carcinoma, Cardiovascular disease, Survival analysis, public health, Cardio-oncology, Risk factor

References

Ahmed, S. (2016, October 9). Distribution of hyperglycemia and related cardiovascular disease risk factors in neglected ethnic community (Biharies) in Dhaka city. http://reposit.library.du.ac.bd:8080/xmlui/handle/123456789/726

Assessment of lipid profile in hepatocellular carcinoma patients: a prospective study in Bangladesh. (2024). Journal of Primeasia., 5(1), 1–8. https://doi.org/10.25163/primeasia.519787

Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2018). Burden of liver diseases in the world. Journal of Hepatology, 70(1), 151–171. https://doi.org/10.1016/j.jhep.2018.09.014

Bashir, M. S., Sayem, M. A., Das, S. S., Das, N., Sultana, A., Rahman, M. M., Shamsuzzaman, M., Paul, P., Hossian, M., & Uddin, M. K. M. (2025). High viral load is a risk factor for hepatocellular carcinoma: Clinical and laboratory insights from a cross-sectional study. Integrative Biomedical Research (Former Journal of Angiotherapy), 9(1), 1–8. https://doi.org/10.25163/angiotherapy.9110219

Ballestri, S. (2014). Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology, 20(7), 1724. https://doi.org/10.3748/wjg.v20.i7.1724

Bashir, M. S., Hossian, M., Uddin, M. K. M., Sayem, M. A., Sultana, A., Rana, F. A., Akter, T., Das, N., Rana, M. S., & Das, S. S. (2025). Association between hepatocellular carcinoma and diabetes mellitus. Journal of Primeasia, 6(1), 1–7. https://doi.org/10.25163/primeasia.6110193

Ceni, E., Mello, T., & Galli, A. (2014). Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World Journal of Gastroenterology, 20(47), 17756–17772. https://doi.org/10.3748/wjg.v20.i47.17756

Cooper, H. (2022). Barriers and Facilitators to Alcohol Reduction in an Integrated Care Intervention among Individuals with Chronic Hepatitis C Virus (Master's thesis, The University of North Carolina at Charlotte).

Das, S. S., Hossain, M. S., Sultana, A., Rana, F. A., Hossen, A., Maowla, M. S., Uddin, M. K. M., Sayem, M. A., Hossian, M., & Bashir, M. S. (2025). The influence of chronic kidney disease on hepatocellular carcinoma. Journal of Primeasia, 6(1), 1–8. https://doi.org/10.25163/primeasia.6110204

Daniel, W. M. (2019). Liver cancer epidemiology and risk factors in South Africa. https://wiredspace.wits.ac.za/items/971653a3-76db-48ef-858e-ee0dd11f6fb2

Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023). Global burden of liver disease: 2023 update. Journal of Hepatology, 79(2), 516–537. https://doi.org/10.1016/j.jhep.2023.03.017

Fouad, Y. M., & Yehia, R. (2014). Hepato-cardiac disorders. World Journal of Hepatology, 6(1), 41. https://doi.org/10.4254/wjh.v6.i1.41

Figueredo, V. M., & Patel, A. (2023). Detrimental effects of alcohol on the heart: hypertension and cardiomyopathy. Reviews in Cardiovascular Medicine, 24(10), 292. https://doi.org/10.31083/j.rcm2410292

Hossian, M., Hasan, M. M., Sultana, A., Das, S. S., Paul, P., Shamsuzzaman, M., Rahman, M. M., Uddin, M. K. M., Sayem, M. A., & Bashir, M. S. (2024). Potential role of Helicobacter pylori infection in hepatocellular carcinoma: A clinical and laboratory-based study. Integrative Biomedical Research (Former Journal of Angiotherapy), 8(12), 1–9. https://doi.org/10.25163/angiotherapy.81210217

Hadi, H. A., & Suwaidi, J. A. (2007). Endothelial dysfunction in diabetes mellitus. Vascular health and risk management, 3(6), 853-876.

Islam, M. R., Yesmin, T., Prapty, A. N., Biswash, M. A. R., Rana, M. S., & Rashid, M. H. O. (2024). Natural environmental sources of resveratrol and its therapeutic role in cancer prevention. Australian Herbal Insight, 7(1), 1–11. https://doi.org/10.25163/ahi.719931

Jung, U., & Choi, M. (2014). Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 15(4), 6184–6223. https://doi.org/10.3390/ijms15046184

Khan, N., Akbar, A., Fahad, S., Faisal, S., & Naushad, M. (2020). Analysis of heart treatment and its impact on socioeconomic conditions on the world Community. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3727588

Matyas, C., Haskó, G., Liaudet, L., Trojnar, E., & Pacher, P. (2020). Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nature Reviews Cardiology, 18(2), 117–135. https://doi.org/10.1038/s41569-020-0433-5

Mak, L., Liu, K., Chirapongsathorn, S., Yew, K. C., Tamaki, N., Rajaram, R. B., Panlilio, M. T., Lui, R., Lee, H. W., Lai, J. C., Kulkarni, A. V., Premkumar, M., Lesmana, C. R. A., Hsu, Y. C., & Huang, D. Q. (2024). Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions. Nature Reviews Gastroenterology & Hepatology, 21(12), 834–851. https://doi.org/10.1038/s41575-024-00967-4

Ohlrogge, A. H., Frost, L., & Schnabel, R. B. (2022). Harmful impact of tobacco smoking and alcohol consumption on the atrial myocardium. Cells, 11(16), 2576. https://doi.org/10.3390/cells11162576

Orozco-Beltran, D., Gil-Guillen, V. F., Redon, J., Martin-Moreno, J. M., Pallares-Carratala, V., Navarro-Perez, J., Valls-Roca, F., Sanchis-Domenech, C., Fernandez-Gimenez, A., Perez-Navarro, A., Bertomeu-Martinez, V., Bertomeu-Gonzalez, V., Cordero, A., De La Torre, M. P., Trillo, J. L., Carratala-Munuera, C., Pita-Fernandez, S., Uso, R., Durazo-Arvizu, R., . . . Tellez-Plaza, M. (2017). Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study. PLoS ONE, 12(10), e0186196. https://doi.org/10.1371/journal.pone.0186196

Parekh, J., Corley, D., & Feng, S. (2012). Diabetes, Hypertension and Hyperlipidemia: Prevalence over time and Impact on Long-Term Survival after liver Transplantation. American Journal of Transplantation, 12(8), 2181–2187. https://doi.org/10.1111/j.1600-6143.2012.04077.x

P, G., & A, N. (2010, March 21). Hematological problems and liver disease. https://www.tropicalgastro.com/articles/30/2/hematological-problems-and-liver-disease.html

Rana, M. S., Bashir, M. S., Das, S. S., Hossain, M., & Barua, S. (2024). Biomarkers for hepatocellular carcinoma: Diagnosis, prognosis, and treatment response assessment – A systematic review. Journal of Primeasia, 5(1), 1–8. https://doi.org/10.25163/primeasia.519784

Salam, M. T., Mou, M. A., et al. (2024). Assessment of lipid profile in hepatocellular carcinoma patients: A prospective study in Bangladesh. Journal of Primeasia, 5(1), 1–8. https://doi.org/10.25163/primeasia.519787

Shah, A. M., Cikes, M., Prasad, N., Li, G., Getchevski, S., Claggett, B., Rizkala, A., Lukashevich, I., O’Meara, E., Ryan, J. J., Shah, S. J., Mullens, W., Zile, M. R., Lam, C. S., McMurray, J. J., & Solomon, S. D. (2019). Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction. Journal of the American College of Cardiology, 74(23), 2858–2873. https://doi.org/10.1016/j.jacc.2019.09.063

Shin, H. S., Jun, B. G., & Yi, S. (2022). Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases. Clinical and Molecular Hepatology, 28(4), 773–789. https://doi.org/10.3350/cmh.2021.0383

Sayiner, M., Golabi, P., & Younossi, Z. M. (2019). Disease burden of hepatocellular Carcinoma: a Global perspective. Digestive Diseases and Sciences, 64(4), 910–917. https://doi.org/10.1007/s10620-019-05537-2

Thylur, R. P., Roy, S. K., Shrivastava, A., LaVeist, T. A., Shankar, S., & Srivastava, R. K. (2020). Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma. JGH Open, 4(3), 351–359. https://doi.org/10.1002/jgh3.12336

Tufael, T., Kar, A., Rashid, M. H. O., Sunny, A. R., Raposo, A., Islam, M. S., Hussain, M. A., Hussen, M. A., Han, H., Coutinho, H. D. M., Ullah, M. S., & Rahman, M. M. (2024). Diagnostic efficacy of tumor markers AFP, CA19-9, and CEA in hepatocellular carcinoma patients. Journal of Angiotherapy, 8(4), 1–10. https://doi.org/10.25163/angiotherapy.849513

Tufael, T., Kar, A., Upadhye, V. J., Dutta, A., Islam, M. R., Sattar, A., Ali, M. E., Akter, J., Bari, K. F., Salam, M. T., Banik, P. C., Khan, M. S. S., & Sunny, A. R. (2024). Significance of serum biomarkers in early diagnosis of hepatocellular carcinoma in patients with Fisher groups. Journal of Angiotherapy, 8(1), 1–9. https://doi.org/10.25163/angiotherapy.819440

Tufael, T., Kar, A., Upadhye, V. J., Dutta, A., Islam, M. R., Sattar, A., Ali, M. E., Akter, J., Bari, K. F., Salam, M. T., Banik, P. C., Khan, M. S. S., & Sunny, A. R. (2024). Significance of serum biomarkers in early diagnosis of hepatocellular carcinoma in patients with Fisher groups. Journal of Angiotherapy, 8(1), 1–9. https://doi.org/10.25163/angiotherapy.819440

T. Akter, M. R. Ali, M. N. A. Faruquee, M. S. Bashir, S. Rahaman, M. A. Rahman, S. Islam. A Comprehensive Study of Hepatitis B Infections in Bangladesh: Epidemiology, Risk Factors and Clinical-Laboratory Correlations. Viral Infections and Cancer Research. 2024; 1(1): 8426.doi:10.59429/vicr.v1i1.8426

Tang, L., Marcell, L., & Kottilil, S. (2016). Systemic manifestations of hepatitis C infection. Infectious Agents and Cancer, 11(1). https://doi.org/10.1186/s13027-016-0076-7

Uddin, M. K. M., Sultana, A., Rahman, M. M., Shamsuzzaman, M., Paul, P., Hasan, M. M., Sayem, M. A., Bashir, M. S., Das, S. S., & Hossian, M. (2025). Cardiovascular complications in patients with hepatocellular carcinoma. Integrative Biomedical Research (Former Journal of Angiotherapy), 9(1), 1–8. https://doi.org/10.25163/angiotherapy.9110218